Suppr超能文献

1997 年至 2017 年期间斯洛文尼亚门诊大环内酯类药物使用量减少与侵袭性肺炎链球菌分离株大环内酯类耐药性之间无相关性。

Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017.

机构信息

National Laboratory of Health, Environment and Food, Department for Public Health Microbiology, Grablovičeva 44, 1000 Ljubljana, Slovenia.

National Laboratory of Health, Environment and Food, Department for Public Health Microbiology, Grablovičeva 44, 1000 Ljubljana, Slovenia.

出版信息

J Glob Antimicrob Resist. 2019 Mar;16:242-248. doi: 10.1016/j.jgar.2018.10.022. Epub 2018 Nov 1.

Abstract

OBJECTIVES

The objective of this study was to investigate the correlation between decreased national consumption of macrolides and resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017.

METHODS

A total of 4241 invasive S. pneumoniae isolates were collected in Slovenia from 1997 to 2017. The presence of erm(B), mef(E), mef(A) and erm(TR) genes was determined by PCR in 612 erythromycin-resistant isolates. Selected isolates carrying the mef(A) gene were further examined by pulsed-field gel electrophoresis (PFGE). Multilocus sequence typing (MLST) was performed for 161 erythromycin-resistant isolates from 2004 to 2009.

RESULTS

Consumption of macrolides decreased by 42.5% between 1997 and 2017, and by 57.0% from the highest consumption during 1999 to 2017. Resistance of S. pneumoniae increased by 120.7% in the same period, from 5.8% in 1997 to 12.8% in 2017. The most prevalent serotypes among macrolide-resistant isolates were 14 (54.9%), 19A (9.0%), 19F (8.3%), 6B (7.2%), 6A (5.2%) and 9V (19; 3.0%). The most prevalent determinant of macrolide resistance in the observed period was erm(B) (43.0%; 263/612), followed by mef(A) (36.3%; 222/612) and mef(E) (14.9%; 91/612). During the study period, an increasing trend in serotype 14, mef(A)-carrying isolates was observed, with a peak in 2011 (P<0.001); 63/71 isolates (88.7%) with the mef(A) gene were clonally related and were related to the international England-9 clonal cluster.

CONCLUSIONS

The reason for the observed increase in macrolide resistance among invasive S. pneumoniae in Slovenia despite decreased macrolide consumption was spread of the England-9 clonal cluster.

摘要

目的

本研究旨在调查 1997-2017 年间斯洛文尼亚侵袭性肺炎链球菌分离株中大环内酯类药物耐药性与国家消耗量下降之间的相关性。

方法

1997 年至 2017 年期间,在斯洛文尼亚共采集了 4241 株侵袭性肺炎链球菌分离株。612 株红霉素耐药株采用 PCR 检测 erm(B)、mef(E)、mef(A)和 erm(TR)基因的存在。对携带 mef(A)基因的选定分离株进一步进行脉冲场凝胶电泳 (PFGE)检测。对 2004 年至 2009 年的 161 株红霉素耐药分离株进行多位点序列分型 (MLST)。

结果

1997 年至 2017 年间,大环内酯类药物的消耗量下降了 42.5%,2017 年与 1999 年至 2017 年的最高消耗量相比下降了 57.0%。同期肺炎链球菌的耐药性增加了 120.7%,从 1997 年的 5.8%上升至 2017 年的 12.8%。大环内酯类耐药分离株中最常见的血清型为 14 型(54.9%)、19A 型(9.0%)、19F 型(8.3%)、6B 型(7.2%)、6A 型(5.2%)和 9V 型(19 型;3.0%)。在观察期内,大环内酯类药物耐药的最常见决定因素是 erm(B)(43.0%;263/612),其次是 mef(A)(36.3%;222/612)和 mef(E)(14.9%;91/612)。在研究期间,观察到血清型 14 和携带 mef(A)基因的分离株呈上升趋势,2011 年达到高峰(P<0.001);71 株携带 mef(A)基因的分离株中,有 63 株(88.7%)呈克隆相关,与国际英格兰 9 克隆群相关。

结论

尽管大环内酯类药物消耗量下降,但斯洛文尼亚侵袭性肺炎链球菌中观察到的大环内酯类药物耐药性增加的原因是英格兰 9 克隆群的传播。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验